Skip to main content
Erschienen in: Pediatric Surgery International 4/2012

01.04.2012 | Original Article

PELD score and age as a prognostic index of biliary atresia patients undergoing Kasai portoenterostomy

verfasst von: Jinsoo Rhu, Soo-Min Jung, Yon Ho Choe, Jeong-Meen Seo, Suk-Koo Lee

Erschienen in: Pediatric Surgery International | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was designed to evaluate the validity of the pediatric end-stage liver disease (PELD) score as a prognostic index of native liver survival in biliary atresia before Kasai portoenterostomy.

Methods

Medical records of 63 patients who underwent Kasai portoenterostomy at our hospital were reviewed retrospectively. Rate of jaundice clearance and cumulative survival with native liver were calculated. Patients who were alive and did not require transplantation until the last follow up were included in the native-liver survival group. And patients who underwent any event, defined as death without transplantation, transplantation or listing for transplantation, were included in the native-liver failure group. Cox analysis was done.

Results

10-year survival rate with native liver was 41.9%. PELD scores of ≥15 and an age at operation of ≥60 days were found to be significant risk factors of failure(P = 0.007, OR = 2.851 and P = 0.010, OR = 3.222, respectively). Furthermore, patients with both risk factors showed significantly higher risk of failure (P = 0.001, OR = 8.809).

Conclusion

Since failure rate is higher for patients with high PELD score and older age, these factors should be helpful in estimating the prognosis. And with high-risk patients, cautious monitoring and consultation should be made whether the liver fails and requires transplantation.
Literatur
1.
Zurück zum Zitat Davenport M, Ure BM, Petersen C, Kobayashi H (2007) Surgery for biliary atresia: is there a European consensus? Eur J Pediatr Surg 17:180–183PubMedCrossRef Davenport M, Ure BM, Petersen C, Kobayashi H (2007) Surgery for biliary atresia: is there a European consensus? Eur J Pediatr Surg 17:180–183PubMedCrossRef
2.
Zurück zum Zitat Serinet MO, Wildhaber BE, Broue P, Lachaux A, Sarles J, Jacquemin E, Gauthier F, Chardot C (2009) Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics 123:1280–1286PubMedCrossRef Serinet MO, Wildhaber BE, Broue P, Lachaux A, Sarles J, Jacquemin E, Gauthier F, Chardot C (2009) Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics 123:1280–1286PubMedCrossRef
3.
Zurück zum Zitat Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L (1997) A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 226:348–353 Discussion 353–345PubMedCrossRef Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L (1997) A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 226:348–353 Discussion 353–345PubMedCrossRef
4.
Zurück zum Zitat Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B (1999) Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 30:606–611PubMedCrossRef Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B (1999) Prognosis of biliary atresia in the era of liver transplantation: French national study from 1986 to 1996. Hepatology 30:606–611PubMedCrossRef
5.
Zurück zum Zitat Wong KK, Chung PH, Chan IH, Lan LC, Tam PK (2010) Performing Kasai portoenterostomy beyond 60 days of life is not necessarily associated with a worse outcome. J Pediatr Gastroenterol Nutr 51:631–634PubMedCrossRef Wong KK, Chung PH, Chan IH, Lan LC, Tam PK (2010) Performing Kasai portoenterostomy beyond 60 days of life is not necessarily associated with a worse outcome. J Pediatr Gastroenterol Nutr 51:631–634PubMedCrossRef
6.
Zurück zum Zitat Cobben DC, Peeters PM, Nap RE (2005) The Kasai portoenterostomy for biliary atresia: a review of a 27-year experience with 81 patients. J Pediatr Surg 40:1510–1511 Author reply 1511PubMedCrossRef Cobben DC, Peeters PM, Nap RE (2005) The Kasai portoenterostomy for biliary atresia: a review of a 27-year experience with 81 patients. J Pediatr Surg 40:1510–1511 Author reply 1511PubMedCrossRef
7.
Zurück zum Zitat Shinkai M, Ohhama Y, Take H, Fukuzato Y, Fujita S, Nishi T (2003) Evaluation of the PELD risk score as a severity index of biliary atresia. J Pediatr Surg 38:1001–1004PubMedCrossRef Shinkai M, Ohhama Y, Take H, Fukuzato Y, Fujita S, Nishi T (2003) Evaluation of the PELD risk score as a severity index of biliary atresia. J Pediatr Surg 38:1001–1004PubMedCrossRef
8.
Zurück zum Zitat Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7:567–580PubMedCrossRef Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7:567–580PubMedCrossRef
9.
Zurück zum Zitat Azarow KS, Phillips MJ, Sandler AD, Hagerstrand I, Superina RA (1997) Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg 32:168–172 Discussion 172–164PubMedCrossRef Azarow KS, Phillips MJ, Sandler AD, Hagerstrand I, Superina RA (1997) Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg 32:168–172 Discussion 172–164PubMedCrossRef
10.
Zurück zum Zitat Chitsaz E, Schreiber RA, Collet JP, Kaczorowski J (2009) Biliary atresia: the timing needs a changin’. Can J Public Health 100:475–477PubMed Chitsaz E, Schreiber RA, Collet JP, Kaczorowski J (2009) Biliary atresia: the timing needs a changin’. Can J Public Health 100:475–477PubMed
11.
Zurück zum Zitat Lien TH, Chang MH, Wu JF, Chen HL, Lee HC, Chen AC, Tiao MM, Wu TC, Yang YJ, Lin CC, Lai MW, Hsu HY, Ni YH (2011) Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology 53:202–208PubMedCrossRef Lien TH, Chang MH, Wu JF, Chen HL, Lee HC, Chen AC, Tiao MM, Wu TC, Yang YJ, Lin CC, Lai MW, Hsu HY, Ni YH (2011) Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology 53:202–208PubMedCrossRef
12.
Zurück zum Zitat Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, Shepherd R, Rosenthal P, Hoofnagle JH, Sokol RJ (2006) A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 148:467–474PubMedCrossRef Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, Shepherd R, Rosenthal P, Hoofnagle JH, Sokol RJ (2006) A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 148:467–474PubMedCrossRef
13.
Zurück zum Zitat Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K (2003) Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 38:997–1000PubMedCrossRef Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K (2003) Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 38:997–1000PubMedCrossRef
14.
Zurück zum Zitat Davenport M, Ong E, Sharif K, Alizai N, McClean P, Hadzic N, Kelly DA (2011) Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg 46:1689–1694PubMedCrossRef Davenport M, Ong E, Sharif K, Alizai N, McClean P, Hadzic N, Kelly DA (2011) Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg 46:1689–1694PubMedCrossRef
15.
Zurück zum Zitat de Vries W, de Langen ZJ, Groen H, Scheenstra R, Peeters PM, Hulscher JB, Verkade HJ (2011) Biliary Atresia in The Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr [Epub ahead of print] de Vries W, de Langen ZJ, Groen H, Scheenstra R, Peeters PM, Hulscher JB, Verkade HJ (2011) Biliary Atresia in The Netherlands: outcome of patients diagnosed between 1987 and 2008. J Pediatr [Epub ahead of print]
16.
Zurück zum Zitat Davenport M, Puricelli V, Farrant P, Hadzic N, Mieli-Vergani G, Portmann B, Howard ER (2004) The outcome of the older (> or = 100 days) infant with biliary atresia. J Pediatr Surg 39:575–581PubMedCrossRef Davenport M, Puricelli V, Farrant P, Hadzic N, Mieli-Vergani G, Portmann B, Howard ER (2004) The outcome of the older (> or = 100 days) infant with biliary atresia. J Pediatr Surg 39:575–581PubMedCrossRef
17.
Zurück zum Zitat Nio M, Sasaki H, Wada M, Kazama T, Nishi K, Tanaka H (2010) Impact of age at Kasai operation on short- and long-term outcomes of type III biliary atresia at a single institution. J Pediatr Surg 45:2361–2363PubMedCrossRef Nio M, Sasaki H, Wada M, Kazama T, Nishi K, Tanaka H (2010) Impact of age at Kasai operation on short- and long-term outcomes of type III biliary atresia at a single institution. J Pediatr Surg 45:2361–2363PubMedCrossRef
Metadaten
Titel
PELD score and age as a prognostic index of biliary atresia patients undergoing Kasai portoenterostomy
verfasst von
Jinsoo Rhu
Soo-Min Jung
Yon Ho Choe
Jeong-Meen Seo
Suk-Koo Lee
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 4/2012
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-012-3060-3

Weitere Artikel der Ausgabe 4/2012

Pediatric Surgery International 4/2012 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.